Zydus Cadila launches new drug for cancer therapy
15 Feb 2008
Mumbai: Zydus Cadila has launched `Nudoxa', a drug that can be used in the treatment of cancer.
Nudoxa is a novel drug delivery system (NDDS) product used in the chemotherapy treatment of various types of cancers, Zydus Cadila said in a filling with the Bombay Stock Exchange (BSE).
"Nudoxa addresses the need for a drug that has reduced toxicity and side effects," Cadila said in the filing.
The drug is particularly used for treating breast and ovarian cancer and its unique drug delivery system is a breakthrough in cancer therapy Cadila said, adding, that the drug offers the benefits of Pegylaled-Liposomal Doxorubiein, which is used as an oncology drug
Pegylated-Liposomal Doxorubicin, however, may cause side effects like skin eruptions, it said.
Nudoxa which has patent rights in India and South Africa, has filed for patents in EU, the US and Japan.
the drug is manufactured by Zydus-BSV Pharma Pvt Ltd, the joint venture of Zydus Cadila and Bharat Serums and Vaccines Pvt Ltd and marketed by Zydus Biogen.
